Ticker >

Sakar Healthcare share price

Sakar Healthcare Ltd.

NSE: SAKAR SECTOR: Pharmaceuticals & Drugs  19k   72   10

368.30
+6.35 (1.75%)
NSE: 28 Mar 4:00 PM

Price Summary

Today's High

₹ 374

Today's Low

₹ 363

52 Week High

₹ 479

52 Week Low

₹ 195.05

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

801.05 Cr.

Enterprise Value

920.14 Cr.

No. of Shares

2.17 Cr.

P/E

64.22

P/B

3.11

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  118.32

CASH

0.09 Cr.

DEBT

119.18 Cr.

Promoter Holding

53.15 %

EPS (TTM)

₹  5.74

Sales Growth

4%

ROE

8.48 %

ROCE

8.95%

Profit Growth

-16.3 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year4%
3 Year17.13%
5 Year20.23%

Profit Growth

1 Year-16.3%
3 Year9.86%
5 Year27.31%

ROE%

1 Year8.48%
3 Year11.29%
5 Year11.55%

ROCE %

1 Year8.95%
3 Year11.41%
5 Year13.14%

Debt/Equity

0.6872

Price to Cash Flow

24.02

Interest Cover Ratio

3.84967714884696

CFO/PAT (5 Yr. Avg.)

2.1568531718287

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 53.15 0
Sep 2023 54.15 0
Jun 2023 60.72 0
Mar 2023 60.72 0
Dec 2022 62.1 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 17.1336999556981% for the Past 3 years.
  • The Company has been maintaining an effective average operating margins of 24.0060787162063% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -50.329172582851 days.
  • The company has a good cash flow management; CFO/PAT stands at 2.1568531718287.
  • The company has a high promoter holding of 53.15%.

 Limitations

  • The company has shown a poor profit growth of 9.85837585877039% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 33.47 40.65 38.99 34.08 37.23
Total Expenditure 24.67 32.87 29.96 24.72 28.22
Operating Profit 8.8 7.78 9.03 9.36 9.01
Other Income 1.85 1.82 1.52 0.66 0.23
Interest 1.95 2.15 2.08 1.65 1.79
Depreciation 4.1 3.55 4.52 4.22 4.45
Exceptional Items 0 -0.01 0 0 0
Profit Before Tax 4.61 3.89 3.95 4.15 3
Tax 0.6 -0.04 1.11 0.52 0.93
Profit After Tax 4.01 3.92 2.84 3.64 2.07
Adjusted EPS (Rs) 2.16 2.06 1.49 1.7 0.95

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 68.25 82.98 94.74 128.23 133.36
Total Expenditure 51.39 63.43 72.12 98.81 100.09
Operating Profit 16.86 19.55 22.62 29.41 33.27
Other Income 0.68 2.02 1.18 2.17 4.67
Interest 2.27 2.26 2.49 2.91 5.96
Depreciation 6.04 7.08 8.06 9.67 14.99
Exceptional Items 0 0 0 0 -0.01
Profit Before Tax 9.23 12.23 13.24 19.01 16.99
Tax 2.54 2.6 2.55 3.77 4.23
Net Profit 6.69 9.62 10.69 15.24 12.76
Adjusted EPS (Rs.) 4.47 6.43 6.85 8.9 6.7

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 14.96 14.96 15.62 17.12 19.04
Total Reserves 56.77 66.36 82.84 110.42 154.39
Borrowings 5.21 12.47 38.45 85.01 98.23
Other N/C liabilities 6.55 7.09 7.62 8.53 10.27
Current liabilities 13.88 14.24 33.27 46.78 54.49
Total Liabilities 97.38 115.12 177.8 267.85 336.42
Assets
Net Block 63.54 65.69 69.1 204.65 266.64
Capital WIP 8.66 13.1 48.92 1.23 6.45
Intangible WIP 0 0 0 0 0
Investments 0 0.01 0.01 0.01 0.01
Loans & Advances 5.13 14.68 25.97 11.86 7.33
Other N/C Assets 0 0 0 0 0
Current Assets 20.06 21.65 33.8 50.1 55.99
Total Assets 97.38 115.12 177.8 267.85 336.42
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 9.23 12.23 13.24 19.01 16.88
Adjustment 8.09 9.19 8.9 12.5 20.14
Changes in Assets & Liabilities 0.21 0.15 -6.83 4.09 0.6
Tax Paid -1.4 -2.77 -0.73 0.19 -4.27
Operating Cash Flow 16.14 18.79 14.58 35.79 33.34
Investing Cash Flow -24.91 -22.34 -46.83 -90.4 -74.38
Financing Cash Flow 8.77 3.48 32.03 54.56 41.1
Net Cash Flow 0 -0.07 -0.22 -0.05 0.06

Corporate Actions

Investors Details

PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
promoters 62.10 60.72 60.72 54.15 53.15
ritaben shah 1.32 1.29 1.29 1.15 1.13
sanjay s shah - 52.04 52.04 46.41 45.56
shah aarsh - 6.87 6.87 6.12 6.01
shah ayushi - - - 0.47 0.46
ayushi s shah 0.54 0.53 0.53 - -
aarsh sanjay shah 7.02 - - - -
sanjay s shah 53.22 - - - -
PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
investors 37.90 39.28 39.28 45.85 46.85
cobra india (mauritius) l... - 7.86 7.86 7.01 6.86
hbm healthcare investment... - 7.88 7.88 7.03 6.90
hi-tech chemicals limited... - - - - 1.84
llp 0.03 0.18 0.18 0.15 0.15
subhash phootarmal rathod... - - 2.79 2.66 2.61
tata capital healthcare f... - - - 10.82 10.62
subhash rathod 2.88 2.79 - - -
cobra india (mauritius) ... 8.06 - - - -
hbm healthcare investmen... 8.06 - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Sakar Healthcare - Quaterly Results10 Feb 2024, 12:00PM Sakar Healthcare - Quaterly Results10 Feb 2024, 12:00PM Sakar Healthcare - Quaterly Results10 Feb 2024, 12:00PM Sakar Healthcare - Quaterly Results6 Nov 2023, 12:00PM Sakar Healthcare - Quaterly Results6 Nov 2023, 12:00PM Sakar Healthcare - Quaterly Results14 Aug 2023, 12:00PM Sakar Healthcare - Quaterly Results14 Aug 2023, 12:00PM Sakar Healthcare inks pact with Ferring Pharmaceuticals, Bazell Pharma 18 May 2023, 11:00AM Sakar Healthcare inks pact with Pharmaceutical Oriented Services11 May 2023, 12:31PM Sakar Healthcare - Quaterly Results10 Feb 2023, 12:00PM Sakar Healthcare - Quaterly Results10 Feb 2023, 12:00PM Sakar Healthcare - Quaterly Results10 Feb 2023, 12:00PM Sakar Healthcare - Quaterly Results22 Oct 2022, 12:00PM Sakar Healthcare - Quaterly Results22 Oct 2022, 12:00PM Sakar Healthcare - Quaterly Results22 Oct 2022, 12:00PM Sakar Healthcare’s OSD, API blocks get WHO GMP approval from FDCA 12 Oct 2022, 12:58PM Sakar Healthcare signs agreement with Zydus Life Sciences 7 Oct 2022, 10:10AM Sakar Healthcare - Quaterly Results6 Aug 2022, 12:00PM Sakar Healthcare - Quaterly Results6 Aug 2022, 12:00PM Sakar Healthcare - Quaterly Results6 Aug 2022, 12:00PM Sakar Healthcare - Quaterly Results20 May 2022, 12:00PM Sakar Healthcare - Quaterly Results20 May 2022, 12:00PM Sakar Healthcare - Quaterly Results20 May 2022, 12:00PM Sakar Healthcare - Quaterly Results8 Feb 2022, 12:00PM Sakar Healthcare - Quaterly Results8 Feb 2022, 12:00PM Sakar Healthcare - Quaterly Results8 Feb 2022, 12:00PM Sakar Healthcare gets EU GMP approval to manufacture, supply products to Europe 7 Oct 2020, 3:55PM

Sakar Healthcare Stock Price Analysis and Quick Research Report. Is Sakar Healthcare an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Sakar Healthcare and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Sakar Healthcare cash from the operating activity was Rs 33.344 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Sakar Healthcare has a Debt to Equity ratio of 0.6872 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Sakar Healthcare , the EPS growth was -24.746192893401 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Sakar Healthcare has OPM of 24.9476975682181 % which is a good sign for profitability.
     
  • ROE: Sakar Healthcare have a poor ROE of 8.47835108544438 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Sakar Healthcare is Rs 368.3. One can use valuation calculators of ticker to know if Sakar Healthcare share price is undervalued or overvalued.
Last Updated on:
Brief about Sakar Healthcare
X